Significance of immunohistochemical expression of p27 and involucrin as the marker of cellular differentiation of squamous cell carcinoma of the esophagus

Oncology

Volumn 71, Issue 5-6, 2007, Pages 402-410

  Nozoe, Tadahiro ^a   Oyama, Tsunehiro ^a   Takenoyama, Mistuhiro ^a   Hanagiri, Takeshi ^a   Sugio, Kenji ^a   Yasumoto, Kosei ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cellular differentiation; Esophagus; Involucrin; p27; Squamous cell carcinoma

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; INVOLUCRIN; PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CORRELATION ANALYSIS; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEIN PRECURSORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 35348835667     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108611     Document Type: Article

References (39)

1. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI: A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 1994;14:3683-3694.
2. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW: p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-323.
3. Ohtsubo M, Roberts JM: Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 1993;259:1908-1912.
4. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP: p27/Kip1 mutation found in breast cancer. Cancer Res 1996;56:2400-2404.
5. Hengst L, Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 1996;271:1861-1864.
6. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997;3:231-234.
7. Slingerland J, Pagano M: Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000;183:10-17.
8. Migita T, Oda Y, Naito S, Tsuneyoshi M: Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma. Cancer 2002;94:973-979.
9. Shapira M, Ben-Izhak O, Linn S, Futerman B, Minkov I, Hershko DD: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 2005;103:1336-1346.
10. Anayama T, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S: Positive correlation between p27Kip1 expression and progression of human esophageal squamous cell carcinoma. Int J Cancer 1998;79:439-443.
11. Shamma A, Doki Y, Tsujinaka T, Shiozaki H, Inoue M, Yano M, Kawanishi K, Monden M: Loss of p27(KIP1) expression predicts poor prognosis in patients with esophageal squamous cell carcinoma. Oncology 2000;58:152-158.
12. Kagawa Y, Yoshida K, Hirai T, Toge T: Significance of the expression of p27Kip1 in esophageal squamous cell carcinomas. Dis Esophagus 2000;13:179-184.
13. Shibata H, Matsubara O, Wakiyama H, Tanaka S: The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus. Pathol Res Pract 2001;197:157-164.
14. Ohbu M, Saegusa M, Okayasu I: Apoptosis and cellular proliferation in oesophageal squamous cell carcinomas: differences between keratinizing and nonkeratinizing types. Virchows Arch 1995;427:271-276.
15. Nozoe T, Korenaga D, Itoh S, Futatsugi M, Maehara Y: Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol 2002;128:691-696.
16. Nozoe T, Takahashi I, Baba H, Maehara Y: Relationship between intracellular localization of p34cdc2 protein and differentiation of esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2005;131:179-183.
17. Nozoe T, Ezaki T, Kabashima A, Baba H, Maehara Y: Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus. Am J Surg 2005;189:110-115.
18. Eckert RL, Green H: Structure and evolution of the human involucrin gene. Cell 1986;46:583-589.
19. Crish JF, Howard JM, Zaim TM, Murthy S, Eckert RL: Tissue-specific and differentiation-appropriate expression of the human involucrin gene in transgenic mice: an abnormal epidermal phenotype. Differentiation 1993;53:191-200.
20. Takahashi H, Kobayashi H, Matsuo S, Iizuka H: Repression of involucrin gene expression by transcriptional enhancer factor 1 (TEF-1). Arch Dermatol Res 1995;287:740-746.
21. Rice RH, Green H: Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell 1979;18:681-694.
22. Banks-Schlegel S, Green H: Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J Cell Biol 1981;90:732-737.
23. Japanese Society for Esophageal Diseases: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, 9th edition: preface, general principles, part I. Esophagus 2004;1:61-88.
24. Japanese Society for Esophageal Diseases: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus, 9th edition: part II. Esophagus 2004;1:107-125.
25. Sobin LH, Wittekind C: International Union Against Cancer. TNM Classification of Malignant Tumours, ed 5. New York, Wiley-Liss, 1997, pp 54-58.
26. Kammerer U, Kapp M, Gassel AM, Richter T, Tank C, Dietl J, Ruck P: A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem 2001;49:623-630.
27. Nita ME, Nagawa H, Tominaga O, Tsuno N, Hatano K, Kitayama J, Tsuruo T, Domene CE, Muto T: p21Waf1/Cip1 expression is a prognostic marker in curatively resected esophageal squamous cell carcinoma, but not p27Kip1, p53, or Rb. Ann Surg Oncol 1999;6:481-488.
28. Itami A, Shimada Y, Watanabe G, Imamura M: Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Oncology 1999;57:311-317.
29. Wang QM, Jones JB, Studzinski GP: Cyclindependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 1996;56:264-267.
30. Coats S, Flanagan WM, Nourse J, Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996;272:877-880.
31. Walts AE, Said JW, Siegel MB, Banks-Schlegel S: Involucrin, a marker of squamous and urothelial differentiation. An immunohistochemical study on its distribution in normal and neoplastic tissues. J Pathol 1985;145:329-340.
32. Nair SA, Nair MB, Jayaprakash PG, Rajalekshmy TN, Nair MK, Pillai MR: Involucrin and tumor progression in the uterine cervix. Pathobiology 1996;64:333-338.
33. van Bommel PF, Kenemans P, Helmerhorst TJ, Gallee MP, Ivanyi D: Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix. Cancer 1994;74:2314-2320.
34. Roland NJ, Rowley H, Scraggs M, Johnson P, Jones AS: MIB-1 and involucrin expression in laryngeal squamous carcinoma: the relationship to host and tumour factors and survival. Clin Otolaryngol Allied Sci 1996;21:429-438.
35. Kaganoi J, Watanabe G, Okabe M, Nagatani S, Kawabe A, Shimada Y, Imamura M, Sakai Y: STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo. Ann Surg Oncol 2007;14:1405-1415.
36. Okamura T, Shimada Y, Imamura M, Yasumoto S: Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene 2003;22:4017-4026.
37. Fujii T, Kato S, Yamana H, Tanaka Y, Fujita H, Shirouzu K, Morimatsu M: Expression of G1 cell cycle markers and the effect of adenovirus-mediated overexpression of p21Waf-1 in squamous cell carcinoma of the esophagus. Int J Oncol 2001;18:157-163.
38. Said JW, Nash G, Sassoon AF, Shintaku IP, Banks-Schlegel S: Involucrin in lung tumors. A specific marker for squamous differentiation. Lab Invest 1983;49:563-568.
39. Suo Z, Holm R, Nesland JM: Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours. Histopathology 1993;23:45-54.